Related Experiment Video
Updated: Nov 4, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The p70S6K/PI3K/MAPK feedback loop releases the inhibition effect of high-dose rapamycin on rat mesangial cell
Jihua Tian1, Sijia Chang1, He Ji1
1Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan, Shanxi, China.
Abstract:
Glomerular mesangial cell (MC) proliferation is one of the causative factors of glomerular diseases and one of their prominent pathological features. Rapamycin can inhibit MC proliferation and slow the progression to chronic renal fibrosis. The present study was designed to observe the role of rapamycin in MC proliferation and to explore the mechanism by which rapamycin acts on Akt and MAPK/ERK1/2 pathways in mesangial cells. MTT assay and flow cytometry were used to evaluate the proliferation and the cell cycle phase of glomerular mesangial cells respectively. The mRNA expression level of p70S6K was detected by RT-qPCR. Western blotting was performed to determine p70S6K, PI3K/Akt, and PI3K/MAPK protein expression. We found that rapamycin could reduce mesangial cell proliferation and arrest the cell cycle in the G1 phase, however the inhibition effect of 1000 nmol/L rapamycin was not higher than that in the 100 nmol/L group. The results of western blotting showed that 1000 nmol/L rapamycin more significantly inhibited the phosphorylation of p70S6K than 100 nmol/L, suggesting there should be another signaling pathway that activates the proliferation of MCs. Moreover, our results revealed that 1000 nmol/L rapamycin led to Raf1-MEK1/2-ERK pathway activation through a p70S6K-PI3K-mediated feedback loop in MCs. This study demonstrated that high-dose rapamycin leads to ERK1/2 activation through a p70S6K/PI3K/MAPK feedback loop in rat MCs, thus reducing the inhibitory effect of rapamycin on MC proliferation.
Insights
High-dose rapamycin may paradoxically activate ERK1/2 pathways in mesangial cells, reducing its effectiveness in inhibiting cell proliferation and slowing chronic kidney disease progression.
Area of Science:
- Nephrology
- Molecular Biology
- Pharmacology
Background:
- Glomerular mesangial cell (MC) proliferation contributes to kidney diseases and fibrosis.
- Rapamycin is known to inhibit MC proliferation and slow disease progression.
Purpose of the Study:
- To investigate rapamycin's effect on MC proliferation.
- To explore the underlying mechanisms involving Akt and MAPK/ERK1/2 pathways.
Main Methods:
- MTT assay and flow cytometry for proliferation and cell cycle analysis.
- RT-qPCR for p70S6K mRNA expression.
- Western blotting for p70S6K, PI3K/Akt, and PI3K/MAPK protein expression.
Main Results:
- Rapamycin reduced MC proliferation and arrested cells in G1 phase.
- 1000 nmol/L rapamycin showed less inhibition than 100 nmol/L, despite greater p70S6K phosphorylation inhibition.
- High-dose rapamycin activated the Raf1-MEK1/2-ERK pathway via a p70S6K-PI3K feedback loop.
Conclusions:
- High-dose rapamycin activates ERK1/2 through a p70S6K/PI3K/MAPK feedback loop in rat MCs.
- This activation diminishes rapamycin's inhibitory effect on MC proliferation.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways

